Optimizing Treatment for Children in the Developing World
Editat de Stuart MacLeod, Suzanne Hill, Gideon Koren, Anders Raneen Limba Engleză Hardback – 29 mai 2015
| Toate formatele și edițiile | Preț | Express |
|---|---|---|
| Paperback (1) | 371.83 lei 6-8 săpt. | |
| Springer International Publishing – 17 oct 2016 | 371.83 lei 6-8 săpt. | |
| Hardback (1) | 378.80 lei 6-8 săpt. | |
| Springer International Publishing – 29 mai 2015 | 378.80 lei 6-8 săpt. |
Preț: 378.80 lei
Preț vechi: 398.74 lei
-5% Nou
Puncte Express: 568
Preț estimativ în valută:
72.49€ • 75.11$ • 60.50£
72.49€ • 75.11$ • 60.50£
Carte tipărită la comandă
Livrare economică 21 martie-04 aprilie
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9783319157498
ISBN-10: 3319157493
Pagini: 350
Ilustrații: XVII, 332 p. 21 illus., 13 illus. in color.
Dimensiuni: 155 x 235 x 25 mm
Greutate: 0.67 kg
Ediția:2015
Editura: Springer International Publishing
Colecția Adis
Locul publicării:Cham, Switzerland
ISBN-10: 3319157493
Pagini: 350
Ilustrații: XVII, 332 p. 21 illus., 13 illus. in color.
Dimensiuni: 155 x 235 x 25 mm
Greutate: 0.67 kg
Ediția:2015
Editura: Springer International Publishing
Colecția Adis
Locul publicării:Cham, Switzerland
V-ar putea interesa
-
-5%Preț: 654.27 lei688.71 lei -
Innovations in Design and Utilization of Measurement Systems to Promote Children's Cognitive, Affective, and Behavioral Health: Workshop SummaryForum on Promoting Children S Cognitive-5%Preț: 211.25 lei222.37 lei -
Opportunities to Promote Children's Behavioral Health: Workshop SummaryForum on Promoting Children&-5%Preț: 237.84 lei250.35 lei -
Using Existing Platforms to Integrate and Coordinate Investments for Children: Summary of a Joint Workshop by the National Academies of Sciences, EngiForum on Investing in Young Children Glo-5%Preț: 254.82 lei268.23 lei -
-20%Preț: 281.98 lei354.52 lei -
Autism Spectrum Disorders: A Special Issue of Child NeuropsychologyNatacha Akshoomoff-23%Preț: 320.36 lei414.78 lei -
Strange and Schafermeyer's Pediatric Emergency Medicine, Fifth EditionRobert Schafermeyer-5%Preț: 1505.20 lei1584.42 lei -
Clinical Manual of Emergency PediatricsJeffrey C. Gershel-5%Preț: 820.25 lei863.43 lei -
Sock Dragon: Living in God's WillGideon KorenPreț: 61.92 lei -
Sleep Disorders in ChildrenSoňa Nevšímalová-5%Preț: 1159.67 lei1220.71 lei -
Pediatric Clinical PharmacologyHannsjörg W. Seyberth-5%Preț: 3181.66 lei3349.11 lei
Public țintă
Professional/practitionerCuprins
Foreword.- Shifting demographics and regional disparities.- Access issues.- Ending stockouts.- Improved formulations and optimal dosing.- Deficient and counterfeit products.- Knowledge gaps in pregnancy and lactation.- Factors enabling improved therapy.- Regulatory science.- Human resource planning.- Information and communications technology.- Pharmaceutical care.- Networks (GRIP, INRUD, MSH, PTN,MYCRN, IABMC).- Research challenges.- Research standards for clinical trials in low and middle income countries.- Innovative appropriate trial methods.- Nutrition/micronutrients.- Impact on therapeutic outcomes.- Drug safety and pharmaco-epidemiology.- Personalized treatment and Pharmacogenomics.- Neglected diseases.- Health outcomes and economics.- Enhanced industry engagement.- Incorporating social science perspectives.- Clinical settings.- Treatment in the community.- Treatment at the district hospital level.- Care of the critically ill child.- Palliative care and pain management. – Conclusion.- The light at the end of the tunnel: future directions.
Notă biografică
Since 2003, Dr Stuart MacLeod has been Professor of Pediatrics at the University of British Columbia in Vancouver, Canada. He was also Director of the Child & Family Research Institute at BC Children’s Hospital until January 2010 and remains a senior clinician scientist at the Institute.
Dr MacLeod received an MD from the University of Toronto in 1967 and completed postgraduate training in clinical pharmacology in 1973 at McGill University where he obtained a PhD in pharmacology in 1972. In the early stages of his career his research interests focused on biochemical pharmacology, drug hepatotoxicity and drug biotransformation. In 1979 Dr MacLeod became the founding leader of a Division of Pediatric Clinical Pharmacology at Toronto’s Hospital for Sick Children. This University of Toronto unit has now thrived for 35 years and is the world’s leading centre for training and research in pediatric pharmacology and toxicology.
Dr MacLeod served as Dean of the Faculty of Health Sciences at McMaster University (1987-1992) and following the deanship founded the Centre for Evaluation of Medicines with a focus on therapeutics teaching, clinical pharmacology, population health sciences and pharmacoepidemiology.
Since 1986, Dr MacLeod has held a major interest in international health with a focus on African maternal-child health. His current scientific interests embrace the multitude of factors that influence safe and effective drug treatments for children and the use of research findings to inform clinical and public policy.
Dr MacLeod received an MD from the University of Toronto in 1967 and completed postgraduate training in clinical pharmacology in 1973 at McGill University where he obtained a PhD in pharmacology in 1972. In the early stages of his career his research interests focused on biochemical pharmacology, drug hepatotoxicity and drug biotransformation. In 1979 Dr MacLeod became the founding leader of a Division of Pediatric Clinical Pharmacology at Toronto’s Hospital for Sick Children. This University of Toronto unit has now thrived for 35 years and is the world’s leading centre for training and research in pediatric pharmacology and toxicology.
Dr MacLeod served as Dean of the Faculty of Health Sciences at McMaster University (1987-1992) and following the deanship founded the Centre for Evaluation of Medicines with a focus on therapeutics teaching, clinical pharmacology, population health sciences and pharmacoepidemiology.
Since 1986, Dr MacLeod has held a major interest in international health with a focus on African maternal-child health. His current scientific interests embrace the multitude of factors that influence safe and effective drug treatments for children and the use of research findings to inform clinical and public policy.
Textul de pe ultima copertă
This book is intended to communicate current best practice in pediatric clinical pharmacology and clinical pharmacy with special consideration of the prevailing circumstances and most pressing needs in developing countries. It also addresses measures that may be taken in countries with emerging economies through organizational and political adjustments to reduce unacceptable levels of morbidity and mortality among children and pregnant women with treatable diseases.
Caracteristici
Comprehensively addresses the health concerns of 1.65 billion children under the age of 14 living in poorly resourced settings; their need for safe and effective evidence-based treatment from conception to adolescence is highlighted Provides a unique perspective on therapeutic decision-making, pediatric pharmacology and pharmacy through a development lens Emphasizes the importance of access to treatment validated for children at every age and stage of development…an issue that goes well beyond affordability